2019
DOI: 10.1590/1089-6891v20e-34543
|View full text |Cite
|
Sign up to set email alerts
|

IMUNOMARCAÇÃO DE TGF-β EM PRÓSTATAS CANINAS NORMAIS E COM LESÕES PROLIFERATIVAS

Abstract: Resumo O fator de crescimento transformador-β (TGF-β), um mediador do crescimento prostático, induz a angiogênese e inibe a proliferação celular. Neste estudo, esse marcador foi utilizado com o objetivo de avaliar sua imunomarcação no tecido normal e com lesões proliferativas benignas, pré-neoplásicas e neoplásicas da próstata canina. Para isso, foram selecionadas 54 glândulas com histomorfologia normal, hiperplasia prostática benigna (HPB) epitelial, HPB estromal, atrofia inflamatória proliferativa (PIA), neo… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
1
1

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Despite exhibiting heterogeneous labeling for androgen receptors, basal cells in these lesions are believed to act in prostate tumor development with significant potential for proliferation [ 44 ]. Moreover, PIN exhibits an immunophenotype similar to PIA and canine PC with regard to cell cycle regulators [ 36 ], showing lower expression of TGF-β in epithelial cells and tissue stroma, referring to the impossibility of this cytokine to inhibit cell proliferation [ 45 ].…”
Section: Preneoplastic Prostatic Lesionsmentioning
confidence: 99%
“…Despite exhibiting heterogeneous labeling for androgen receptors, basal cells in these lesions are believed to act in prostate tumor development with significant potential for proliferation [ 44 ]. Moreover, PIN exhibits an immunophenotype similar to PIA and canine PC with regard to cell cycle regulators [ 36 ], showing lower expression of TGF-β in epithelial cells and tissue stroma, referring to the impossibility of this cytokine to inhibit cell proliferation [ 45 ].…”
Section: Preneoplastic Prostatic Lesionsmentioning
confidence: 99%
“…The function of TGFβ in the prostate is related to prostate growth and angiogenesis, and it has been shown to be associated with prostate cancer [14]. It accumulates in stromal cells, contributing to the progression of proliferative lesions that occur in the prostate [15]. However, Lee et al (1999) pointed out that the mode of action of TGFβ in prostatic tissue is variable [14].…”
Section: Introductionmentioning
confidence: 99%